133 related articles for article (PubMed ID: 19493612)
1. Activin is a potent growth suppressor of epithelial ovarian cancer cells.
Ramachandran A; Marshall ES; Love DR; Baguley BC; Shelling AN
Cancer Lett; 2009 Nov; 285(2):157-65. PubMed ID: 19493612
[TBL] [Abstract][Full Text] [Related]
2. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.
Ota T; Klausen C; Salamanca MC; Woo HL; Leung PC; Auersperg N
Differentiation; 2009 Feb; 77(2):162-71. PubMed ID: 19281776
[TBL] [Abstract][Full Text] [Related]
4. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
[TBL] [Abstract][Full Text] [Related]
5. Cell growth regulation through apoptosis by activin in human gastric cancer SNU-16 cell lines.
Kim YI; Kim BH; Khang I; Cho BN; Lee HK
Oncol Rep; 2009 Feb; 21(2):491-7. PubMed ID: 19148527
[TBL] [Abstract][Full Text] [Related]
6. Presence of activin signal transduction in normal ovarian cells and epithelial ovarian carcinoma.
Ito I; Minegishi T; Fukuda J; Shinozaki H; Auersperg N; Leung PC
Br J Cancer; 2000 Apr; 82(8):1415-20. PubMed ID: 10780520
[TBL] [Abstract][Full Text] [Related]
7. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
[TBL] [Abstract][Full Text] [Related]
8. The autocrine effect of activin A on human ovarian clear cell adenocarcinoma cells.
Mabuchi Y; Yamoto M; Minami S; Umesaki N
Oncol Rep; 2006 Aug; 16(2):373-9. PubMed ID: 16820918
[TBL] [Abstract][Full Text] [Related]
9. Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer.
Popadiuk CM; Xiong J; Wells MG; Andrews PG; Dankwa K; Hirasawa K; Lake BB; Kao KR
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2216-23. PubMed ID: 16609037
[TBL] [Abstract][Full Text] [Related]
10. Truncating mutations in the ACVR2 gene attenuates activin signaling in prostate cancer cells.
Rossi MR; Ionov Y; Bakin AV; Cowell JK
Cancer Genet Cytogenet; 2005 Dec; 163(2):123-9. PubMed ID: 16337854
[TBL] [Abstract][Full Text] [Related]
11. Role of hedgehog signaling in ovarian cancer.
Bhattacharya R; Kwon J; Ali B; Wang E; Patra S; Shridhar V; Mukherjee P
Clin Cancer Res; 2008 Dec; 14(23):7659-66. PubMed ID: 19047091
[TBL] [Abstract][Full Text] [Related]
12. Activins and activin antagonists in the human ovary and ovarian cancer.
Reader KL; Gold E
Mol Cell Endocrinol; 2015 Nov; 415():126-32. PubMed ID: 26277402
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel splice variant of AML1b in ovarian cancer patients conferring loss of wild-type tumor suppressive functions.
Nanjundan M; Zhang F; Schmandt R; Smith-McCune K; Mills GB
Oncogene; 2007 Apr; 26(18):2574-84. PubMed ID: 17072347
[TBL] [Abstract][Full Text] [Related]
14. Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy.
Zhang HY; Zhang PN; Sun H
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):81-6. PubMed ID: 19540648
[TBL] [Abstract][Full Text] [Related]
15. Immunological profiling of a panel of human ovarian cancer cell lines.
Carr TM; Adair SJ; Fink MJ; Hogan KT
Cancer Immunol Immunother; 2008 Jan; 57(1):31-42. PubMed ID: 17579858
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 regulates follistatin function in ovarian cancer and human ovarian surface epithelial cells.
Karve TM; Preet A; Sneed R; Salamanca C; Li X; Xu J; Kumar D; Rosen EM; Saha T
PLoS One; 2012; 7(6):e37697. PubMed ID: 22685544
[TBL] [Abstract][Full Text] [Related]
17. High activin A-expression in human neuroblastoma: suppression of malignant potential and correlation with favourable clinical outcome.
Schramm A; von Schuetz V; Christiansen H; Havers W; Papoutsi M; Wilting J; Schweigerer L
Oncogene; 2005 Jan; 24(4):680-7. PubMed ID: 15580313
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of activin A gene by butyrate in human colon cancer cell lines.
Sonoyama K; Pholnukulkit P; Toyoda M; Rutatip S; Kasai T
Am J Physiol Gastrointest Liver Physiol; 2003 Jun; 284(6):G989-95. PubMed ID: 12540370
[TBL] [Abstract][Full Text] [Related]
19. Activin A and bone metastasis.
Leto G
J Cell Physiol; 2010 Nov; 225(2):302-9. PubMed ID: 20533297
[TBL] [Abstract][Full Text] [Related]
20. Gene-expression profiling in epithelial ovarian cancer.
Konstantinopoulos PA; Spentzos D; Cannistra SA
Nat Clin Pract Oncol; 2008 Oct; 5(10):577-87. PubMed ID: 18648354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
